TORX®
Your platform for small molecule discovery chemistry
Make better design decisions and track compound synthesis from start to finish
All small molecule chemistry teams go through a common DMTA process: design molecules, make or synthesize compounds, then test and analyze results before the next iteration. Torx Software supports hypothesis-driven drug discovery, promotes collaboration, and facilitates real-time information exchange to streamline the drug discovery process.
Dedicated stand-alone modules for Design, Make, Test and Analyze work in synergy to give a complete platform. Work with one or more modules:
- Torx Design: Make better design decisions using all the relevant information you have
- Torx Make: Track compound synthesis from start to finish for enhanced productivity
- Torx Test: Seamlessly request compound tests and monitor progress in real time
- Torx Analyze: Inspire design through insightful analysis
Testimonials from customers
The ability to see progress across projects for design and synthesis helps us work out where there are hold-ups so we can make informed resourcing decisions
Top 10 global pharmaceutical company
Torx has revolutionised the way we communicate & prioritise designs within project teams and with our synthetic chemistry CRO partners. Working across multiple projects and with a range of external partners, we have embedded the software into our workflows to improve chemistry delivery. Torx has enabled increased flexibility in working with our collaborators and improved communication of relative priorities. We can make informed decisions quickly and track delivery of key molecules to rapidly advance our programs.
Associate Director, Medicinal Chemistry, Cambridge Biotech
Torx Make has immediately become integral to Monte Rosa’s informatics ecosystem and is fundamental to the way that chemists work. The integration with in-house databases has provided additional efficiencies for our CRO partners and Monte Rosa chemists, removing manual registration steps. Torx Make readily scales with our expanding requirement to leverage more externalized chemistry.
Bernhard Fasching, Vice President, Chemistry at Monte Rosa
There was a huge time saving in back-and-forth communications. I think we saved 2hrs/week/scientist for a total saving of 40hrs/week or 1 full time equivalent (FTE), plus another 4-6 hrs/week/dept head on coordination, equalling almost another FTE.
R&D IT Manager, San Francisco-based biotech
Torx Make has rapidly become a crucial node in Evariste's chemistry platform and is essential to the way we communicate with CROs. Our virtual model means that efficient interaction with our external chemists is fundamentally important and Torx Make has helped significantly in this regard. We look forward to further expanding our use of the Torx platform as Evariste grows.
Alfie Brennan, Chief Scientific Officer, Evariste
It is easy to identify any productivity bottlenecks, make quick and informed decisions about changes to priorities or assignments, and communicate these updates to team members and CROs. By providing immediate, real-time access to design and synthesis information, Torx ensures that we are investing our resources in the most critical compounds.
Toni Kline, Senior Director of Chemistry at Engine Biosciences
We were relying on emails to exchange information, which ended up either in PDFs buried in a file share or in people’s memory. It was difficult to keep track of who was making what, or to find out if something had been done before, which meant that people at different locations were working on the same target and some compounds were re-proposed unnecessarily. There was also the risk of timelines sliding because an important compound went under the radar and wasn’t worked on in a timely manner.
Director of Informatics, Boston-based biotech
The back of the napkin math for us on ROI (return on investment) was a $60K investment/year for $500K in time savings for scientists to do more high value work.
R&D IT Manager, San Francisco-based biotech